Modulating reward and aversion: Insights into addiction from the paraventricular nucleus

Shihao Huang,Cuijie Shi,Dan Tao,Chang Yang,Yixiao Luo
DOI: https://doi.org/10.1111/cns.70046
2024-09-20
CNS Neuroscience & Therapeutics
Abstract:The paraventricular nucleus regulates drug addiction directly by modulating reward and aversion systems or indirectly by affecting stress response and emotional regulation. In this process, the corticotropin‐releasing factor, oxytocin, arginine vasopressin, rostral ventrolateral medulla, neuropeptide Y, agouti‐related peptide, and pro‐opiomelanocortin neurons are involved in the modulation of drug addiction. Background Drug addiction, characterized by compulsive drug use and high relapse rates, arises from complex interactions between reward and aversion systems in the brain. The paraventricular nucleus (PVN), located in the anterior hypothalamus, serves as a neuroendocrine center and is a key component of the hypothalamic–pituitary–adrenal axis. Objective This review aimed to explore how the PVN impacts reward and aversion in drug addiction through stress responses and emotional regulation and to evaluate the potential of PVN as a therapeutic target for drug addiction. Methods We review the current literature, focusing on three main neuron types in the PVN—corticotropin‐releasing factor, oxytocin, and arginine vasopressin neurons—as well as other related neurons, to understand their roles in modulating addiction. Results Existing studies highlight the PVN as a key mediator in addiction, playing a dual role in reward and aversion systems. These findings are crucial for understanding addiction mechanisms and developing targeted therapies. Conclusion The role of PVN in stress response and emotional regulation suggests its potential as a therapeutic target in drug addiction, offering new insights for addiction treatment.
pharmacology & pharmacy,neurosciences
What problem does this paper attempt to address?